Prohost Letter #378 Part 1
Views and Visions
TOP-TIER BIOTECHNOLOGY COMPANIES
We wrote a lot about Gilead (GILD), doing our best to protect investors against negative gossip that filled the media and aimed at misleading and insulting investors’ intelligence. We never lowered our target based on the perpetrated, fabricated stories, which made many investors lose confidence in Gilead’s strategy and sell their stocks, thus, motivating others to sell. For us, as you know, it was an opportunity to accumulate on weakness. We did, and here we are. The sales . . .
This content is for paid subscribers.
Prohost Letters May 27, 2015